semaglutide vs tirzepatide dosage chart chart: complete comparison guide The infographic covers weight-loss medicines

In REDEFINE 1 (overweight/obesity without T2D), CagriSema achieved mean weight reductions of 20.4-22.7% (vs 2.3-3.0% placebo) at 68 weeks, with 53.6% and 34.7% of patients achieving 20% and 25% weight loss, respectively

2021;44(Suppl 1):S12550

Retatrutide is a triple agonist, meaning it activates three distinct hormone receptors GLP-1, GIP, and glucagon

At Bodify, we are committed to delivering exceptional care and results, and we are excited to offer Semaglutide treatments as part of our mission to empower our clients to look and feel their best

Week 2 Finding your rhythm Youll start your medication with guidance from your care team, and begin tracking how your body responds